Applied DNA Submits Request for Emergency Use Authorization to FDA for Linea™ SARS-CoV-2 Mutation Panel
Applied DNA Sciences, Inc. (APDN)
Last applied dna sciences, inc. earnings: 8/10 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
adnas.com/molecular-based-security/investors
Company Research
Source: Business Wire
- Panel is Designed for the Qualitative Detection of Four SARS-CoV-2 Genomic Mutations, Three of Which are Classified by the CDC as Substitutions of Therapeutic Concern -- Panel is Designed to Serve as a Rapid Alternative to Next Generation Sequencing to Identify Patients Infected with COVID-19 that Contain Specific Mutations that May Impact the Efficacy of Certain Antibody Treatments - STONY BROOK, N.Y.--(BUSINESS WIRE)--Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing and nucleic acid-based technologies, announced that it has submitted its request for Emergency Use Authorization (EUA) to the U.S. Food and Drug Administration (FDA) for its Linea™ SARS-CoV-2 Mutation Panel (the “Mutation Panel”). The Mutation Panel is designed for the qualitative detection of the E484K, E484Q, L452R, and N501Y SARS-CoV-2 genetic mutations in samples that have tested positive for COVID-19 on the Company’s EU
Show less
Read more
Impact Snapshot
Event Time:
APDN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
APDN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
APDN alerts
High impacting Applied DNA Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
APDN
News
- Applied DNA Sciences (APDN) Reports Q2 Loss, Tops Revenue Estimates [Yahoo! Finance]Yahoo! Finance
- Applied DNA Announces Second Quarter Fiscal Year 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- Applied DNA Announces Second Quarter Fiscal Year 2024 Financial Results Accesswire
- ‘Significant' Volume of Xinjiang Cotton Mislabeled as US or Brazilian [Yahoo! Finance]Yahoo! Finance
- Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement [Yahoo! Finance]Yahoo! Finance
APDN
Earnings
- 5/10/24 - Miss
APDN
Sec Filings
- 5/10/24 - Form 8-K
- 5/10/24 - Form 10-Q
- 5/1/24 - Form SC
- APDN's page on the SEC website